Name: Latest research reports of Indegene Ltd. authored by IDBI Capital and published by - Trendlyne research reports.
Item: Indegene Ltd.
Rating: 5
Author: IDBI Capital

Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
31 Jul 2026	Indegene	Consensus Share Price Target	514.70	607.13	-	17.96	buy	pdf Detailed Estimates
29 Jul 2026	Indegene	IDBI Capital	514.70	620.00	523.60 (-1.70%)	20.46	Buy	pdf post cache	Broker Report Indegene: Initiating Coverage IDBI Capital market depends on pharma commercialization, medical affairs and regulatory outsourcing with an estimation at over USD 40bn by 2033, yet Indegene's FY26 revenue represents well under 0.2% of this opportunity. Rising drug development costs, patent cliffs, and increasing outsourcing... pdf Copy Link Share on Share on Share on Share on Alert
02 May 2026	Indegene	Motilal Oswal Target	514.70	552.00	499.75 (2.99%)	Target met	Neutral	pdf post cache	Broker Report Performance in line; FY27 likely to be better than FY26 Motilal Oswal Indegene’s 4QFY26 revenue rose to 6.5% QoQ to INR10b (in line with our estimate), while Ex-BioPharm revenue growth stood at 5.6%. pdf Copy Link Share on Share on Share on Share on Alert
02 May 2026	Indegene	ICICI Securities Limited	514.70	620.00	499.75 (2.99%)	20.46	Buy	pdf post cache	Broker Report Robust growth with improving life sciences demand outlook ICICI Securities Limited Indegene showed robust revenue growth performance with broad-based traction across ECS/EMS. Issues in top client seem to have abated for now. pdf Copy Link Share on Share on Share on Share on Alert
31 Jan 2026	Indegene	Motilal Oswal	514.70	550.00	482.40 (6.70%)	Target met	Neutral	pdf post cache	Broker Report Acquisition drives growth with steady organic performance Motilal Oswal Indegene’s 3QFY26 USD revenue rose 15.1% QoQ, aided by the BioPharm acquisition, while organic USD revenue growth stood at 4% QoQ (below our estimate). pdf Copy Link Share on Share on Share on Share on Alert
10 Jul 2024	Indegene	Monarch Networth Capital Limited	514.70	660.00	569.95 (-9.69%)	Target met	Buy	pdf post cache	Broker Report Indegene Limited - Revolutionizing Life Sciences' Marketing Way Monarch Networth Capital Limited pdf Copy Link Share on Share on Share on Share on Alert
03 May 2024	Indegene	HDFC Securities	514.70				IPO Note	pdf post cache	Broker Report IPO Note - Indegene Limited 06052024 HDFC Securities IPO Note - Indegene Limited Indegene Limited (IL) provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products pdf Copy Link Share on Share on Share on Share on Alert
03 May 2024	Indegene	Ventura	514.70				IPO Subscribe	pdf post cache	Broker Report INDEGENE LTD. Ventura IPO NOTE pdf Copy Link Share on Share on Share on Share on Alert
03 May 2024	Indegene	Ashika Research	514.70				IPO Note	pdf post cache	Broker Report Ashika IPO Note Indegene Ltd. Ashika Research pdf Copy Link Share on Share on Share on Share on Alert
03 May 2024	Indegene	SBI Securities	514.70				IPO Subscribe	pdf post cache	Broker Report Indegene Limited IPO Note SBI Securities pdf Copy Link Share on Share on Share on Share on Alert
02 May 2024	Indegene	Hem Securities	514.70				IPO Subscribe	pdf post cache	Broker Report INDEGENE LIMITED Hem Securities pdf Copy Link Share on Share on Share on Share on Alert

High volume today

Indegene Ltd. share price target

Indegene Ltd. has an average share price target of 597.33. The consensus estimate represents an upside of 16.05% from the last price of 514.70. View 4 reports from 3 analysts offering long-term price targets for Indegene Ltd..

Indegene: Initiating Coverage

Performance in line; FY27 likely to be better than FY26

Robust growth with improving life sciences demand outlook

Acquisition drives growth with steady organic performance

Indegene Limited - Revolutionizing Life Sciences' Marketing Way

IPO Note - Indegene Limited 06052024

INDEGENE LTD.

Ashika IPO Note Indegene Ltd.

Indegene Limited IPO Note

INDEGENE LIMITED

Advisor Screeners